Cargando…

Assessment of HPV 16, HPV 18, p16 expression in advanced stage laryngeal cancer patients and prognostic significance()()

INTRODUCTION: Human papilloma virus is an etiological risk factor for a subset of head and neck squamous cell carcinomas. HPV has been proven to be a powerful prognostic biomarker for oropharyngeal cancer, but its role in the larynx has not been explored in depth. The developmental mechanisms of lar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dogantemur, Selman, Ozdemir, Suleyman, Uguz, Aysun, Surmelioglu, Ozgur, Dagkiran, Muhammed, Tarkan, Ozgur, Tuncer, Ulku
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9422527/ https://www.ncbi.nlm.nih.gov/pubmed/31899126 http://dx.doi.org/10.1016/j.bjorl.2019.11.005

Ejemplares similares

The Results of Cochlear Implantation in the Inner Ear Malformations
por: Onan, Elvan, et al.
Publicado: (2022)

Alternating pattern of rhino-orbital–cerebral mucormycosis with COVID-19 in diabetic patients
por: Eker, Caglar, et al.
Publicado: (2022)

Prevalence of HPV 16 and HPV 18 Lineages in Galicia, Spain
por: Pérez, Sonia, et al.
Publicado: (2014)

Clinical Significance of an HPV DNA Chip Test with Emphasis on HPV-16 and/or HPV-18 Detection in Korean Gynecological Patients
por: Yeo, Min-Kyung, et al.
Publicado: (2016)

Frequency of Human Papillomavirus (HPV) 16 and 18 Detection in Paraffin- Embedded Laryngeal Carcinoma Tissue
por: Hosseini, Seyed Zinab, et al.
Publicado: (2017)

Is It Time to Genotype Beyond HPV16 and HPV18 for Cervical Cancer Screening?
por: Chua, Brandon Wen Bing, et al.
Publicado: (2022)

HPV16 and HPV18 Genome Structure, Expression, and Post-Transcriptional Regulation
por: Yu, Lulu, et al.
Publicado: (2022)

Triage of HPV-positive women in Norway using cytology, HPV16/18 genotyping and HPV persistence
por: Arbyn, Marc, et al.
Publicado: (2020)

Assessment of Videos on YouTube(TM) about Nasopharyngeal Cancer in Terms of Accuracy, Reliability and Understandability
por: Eker, Caglar, et al.
Publicado: (2022)

Rapid detection of high-risk HPV16 and HPV18 based on microchip electrophoresis
por: Fan, Zhaoxuan, et al.
Publicado: (2020)

Absence of HPV 16 and 18 DNA in breast cancer.
por: Wrede, D., et al.
Publicado: (1992)

Monitoring HPV16/18 immunisation in England and elsewhere
por: Franceschi, S
Publicado: (2010)

Evolution and Taxonomic Classification of Human Papillomavirus 16 (HPV16)-Related Variant Genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67
por: Chen, Zigui, et al.
Publicado: (2011)

Performance of HPV16/18 in Triage of Cytological Atypical Squamous Cells of Undetermined Significance
por: Cao, Xiaoqin, et al.
Publicado: (2019)

Genetic Diversity in the Major Capsid L1 Protein of HPV-16 and HPV-18 in the Netherlands
por: King, Audrey J., et al.
Publicado: (2016)

Induction of p16 during immortalization by HPV 16 and 18 and not during malignant transformation.
por: Nakao, Y., et al.
Publicado: (1997)

The levels of anti-HPV16/18 and anti-HPV31/33/35/45/52/58 antibodies among AS04-adjuvanted HPV16/18 vaccinated and non-vaccinated Ugandan girls aged 10–16 years
por: Nakalembe, Miriam, et al.
Publicado: (2014)

Cancer stage and pack-years, but not p16 or HPV, are relevant for survival in hypopharyngeal and laryngeal squamous cell carcinomas
por: Dahm, Valerie, et al.
Publicado: (2018)

Significance of HPV16 Viral Load Testing in Anal Cancer
por: Małusecka, Ewa, et al.
Publicado: (2020)

Anti-HPV16 Antibody Titers Prior to an Incident Cervical HPV16/31 Infection
por: Gradissimo, Ana, et al.
Publicado: (2021)

HPV16 infection decreases vaccine-induced HPV16 antibody avidity: the CVT trial
por: Tsang, Sabrina H., et al.
Publicado: (2022)

Human papillomavirus (HPV) vaccination for the prevention of HPV 16/18 induced cervical cancer and its precursors
por: Damm, Oliver, et al.
Publicado: (2009)

HPV16/18 genotyping for the triage of HPV positive women in primary cervical cancer screening in Chile
por: Lagos, Marcela, et al.
Publicado: (2015)

Correction: Genetic Diversity in the Major Capsid L1 Protein of HPV-16 and HPV-18 in the Netherlands
por: King, Audrey J., et al.
Publicado: (2016)

Prevalence of HPV 16 and 18 and attitudes toward HPV vaccination trials in patients with cervical cancer in Mali
por: Téguété, Ibrahima, et al.
Publicado: (2017)

The correlation of HPV16 and HPV18 with local vaginal immunity after the treatment of cervical intraepithelial neoplasia
por: Mu, Lin, et al.
Publicado: (2020)

Genetic Diversity of HPV 16 and HPV 18 Based on Partial Long Control Region in Iranian Women
por: Mobini Kesheh, Mina, et al.
Publicado: (2022)

Interaction of HPV16 and Cutaneous HPV in Head and Neck Cancer
por: Al-Soneidar, Walid A., et al.
Publicado: (2022)

Human papillomavirus (HPV) types 16, 18, 31, 45 DNA loads and HPV-16 integration in persistent and transient infections in young women
por: Ramanakumar, Agnihotram V, et al.
Publicado: (2010)

Genotyping for Human Papillomavirus (HPV) 16/18/52/58 Has a Higher Performance than HPV16/18 Genotyping in Triaging Women with Positive High-risk HPV Test in Northern Thailand
por: Khunamornpong, Surapan, et al.
Publicado: (2016)

More men than women make mucosal IgA antibodies to Human papillomavirus type 16 (HPV-16) and HPV-18: a study of oral HPV and oral HPV antibodies in a normal healthy population
por: Marais, Dianne J, et al.
Publicado: (2006)

Comparison Between Two Detection Methods for HPV16, HPV18 and P16Ink4a Biomarkers in Diagnosis of Abnormal Cervical Cytology
por: Khazaei, Sedigheh, et al.
Publicado: (2016)

Reduction in HPV 16/18 prevalence in sexually active young women following the introduction of HPV immunisation in England()
por: Mesher, D., et al.
Publicado: (2013)

Evaluation of partial genotyping with HPV16/18 for triage of HPV positive, cytology negative women in the COMPACT study
por: Hanley, Sharon J.B., et al.
Publicado: (2021)

HPV DNA methylation at the early promoter and E1/E2 integrity: A comparison between HPV16, HPV18 and HPV45 in cervical cancer
por: Amaro-Filho, Sérgio Menezes, et al.
Publicado: (2018)

HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial
por: van Poelgeest, Mariette I E, et al.
Publicado: (2013)

Introduction and sustained high coverage of the HPV bivalent vaccine leads to a reduction in prevalence of HPV 16/18 and closely related HPV types
por: Kavanagh, K, et al.
Publicado: (2014)

Primary Screening for Cervical Cancer Based on High-Risk Human Papillomavirus (HPV) Detection and HPV 16 and HPV 18 Genotyping, in Comparison to Cytology
por: Agorastos, Theodoros, et al.
Publicado: (2015)

The Distribution and Prevalence of High-Risk HPV Genotypes Other than HPV-16 and HPV-18 among Women Attending Gynecologists’ Offices in Kazakhstan
por: Aimagambetova, Gulzhanat, et al.
Publicado: (2021)

p16 in HPV-associated cancers
por: Munger, Karl, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_hensio19u3a4jqhbe549osflff